Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 35
Healthy Volunteers: t
View:
• Women with indication for elective caesarean section.
• Age less than 35 years old.
• Gestational age less than 38 weeks.
• Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length.
• Singleton pregnancy with no major anomalies
Locations
Other Locations
Egypt
Kafr El-sheikh University Hospital
RECRUITING
Kafr Ash Shaykh, Egypt
Contact Information
Primary
Merna Ashraf Ahmed farid, M.B.B.C.H
mernaashraf2551996@gmail.com
01093030236
Time Frame
Start Date: 2024-06-01
Estimated Completion Date: 2025-08-01
Participants
Target number of participants: 160
Treatments
Active_comparator: Misoprostol before elective cesarean section .
candidates will receive 100mcg Misoprostol one hour before elective caesarean section.
Placebo_comparator: Giving no treatment before elective caesarean section.
candidates will receive no treatment before elective caesarean section.
Related Therapeutic Areas
Sponsors
Leads: Kafrelsheikh University